{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:03:50Z","timestamp":1790471030040,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":194,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000213","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:14:00Z","timestamp":1069366440000},"source":"Crossref","is-referenced-by-count":192,"title":["Thrombolysis for acute ischaemic stroke"],"prefix":"10.1002","author":[{"given":"Joanna M","family":"Wardlaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"del Zoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"key":"10.1002\/14651858.CD000213-BIB1|cit1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2491\/jjsth1970.12.321","article-title":"Clinical evaluation for efficacy of tissue cultured urokinase (TCUK) on cerebral thrombosis by means of multi-centre double blind study (Translated from Japanese)","volume":"12","author":"*Abe","year":"1981","journal-title":"Blood-Vessel"},{"key":"10.1002\/14651858.CD000213-BIB2|cit2","first-page":"359","article-title":"Thrombolytic therapy for cerebral infarction","volume":"3","author":"Abe","year":"1984","journal-title":"Inter Angio"},{"key":"10.1002\/14651858.CD000213-BIB3|cit3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase in acute ischaemic stroke: Does time of therapy administration affect outcome?","volume":"271","author":"*Donnan","year":"1996","journal-title":"Journal of the Americal Medical Association"},{"issue":"suppl 2","key":"10.1002\/14651858.CD000213-BIB4|cit4","first-page":"128","article-title":"Australian Streptokinase trial: Clinical and CT outcome predictors (abstract)","volume":"6","author":"Davis","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB6|cit5","first-page":"182","article-title":"ASK Trial: Risk factors for poor outcome (abstract)","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB5|cit6","first-page":"183","article-title":"ASK Trial - predictors of good outcome","volume":"6","author":"Donnan","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB7|cit7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(95)90484-0","article-title":"Trials of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB8|cit8","series-title":"Stroke","first-page":"2887","article-title":"Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute ischaemic stroke.","author":"Gilligan","year":"2000"},{"issue":"1","key":"10.1002\/14651858.CD000213-BIB9|cit9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/str.32.suppl_1.370-d","article-title":"Early CT changes do not predict parenchymal haemorrhage following streptokinase therapy in acute stroke","volume":"32","author":"Gilligan","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB10|cit10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.50.3.626","article-title":"Streptokinase in acute stroke: Effect on reperfusion and recanalisation","volume":"50","author":"Yasaka","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213-BIB11|cit11","first-page":"659","article-title":"Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis: Multi-center double blind study in comparison with placebo (Translated from Japanese)","volume":"13","author":"Atarashi","year":"1985","journal-title":"Clin Eval"},{"issue":"suppl 1","key":"10.1002\/14651858.CD000213-BIB12|cit12","first-page":"126","article-title":"The ATLANTIS rt-TP (ALteplase) acute stroke trial: final results","volume":"9","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213-BIB14|cit13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rt-PA (Alteplase) 0- to 6- hour Acute Stroke Trial, Part A (A027g). Results of a double-blind, placebo-controlled,multicentre study.","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB13|cit14","first-page":"234","article-title":"The ATLANTIS rt-PA (Alteplase) Acute Stroke Trial - Final Results","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke 1999"},{"key":"10.1002\/14651858.CD000213-BIB15|cit15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.STR.30.2.389","article-title":"Evaluation of early computed tomographic findings in acute ischaemic stroke","volume":"30","author":"Marks","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB17|cit16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/hs0202.102599","article-title":"The ATLANTIS trial: Results for patients treated within three hours of stroke onset.","volume":"33","author":"Albers","year":"2002","journal-title":"Stroke"},{"issue":"suppl 1","key":"10.1002\/14651858.CD000213-BIB16|cit17","first-page":"126","article-title":"The ATLANTIS rt-TP (Alteplase) acute stroke trial: final results","volume":"9","author":"Albers","year":"1999","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213-BIB18|cit18","series-title":"Stroke 1999","first-page":"234","article-title":"The ATLANTIS rt-PA (Alteplase) Acute Stroke Trial - Final Results","author":"Clark","year":"1999"},{"key":"10.1002\/14651858.CD000213-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischaemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomised controlled trial.","volume":"282","author":"Clark","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000213-BIB20|cit20","series-title":"Abstracts of the 7th International Symposium on Thrombolysis and Acute ISchaemic Stroke, 27-28 May 2002, Lyon","first-page":"79","article-title":"Do some patients benefit from rt-PA treatment for acute ischaemic stroke even when treated more than 3 hours after the onset of symptoms?","author":"Kent","year":"2002"},{"key":"10.1002\/14651858.CD000213-BIB21|cit21","unstructured":"The study group of a 5 year National Project of the People's Republic of China conducted by Qingtang Chen Maolin He Intravenous thrombolysis with Urokinase for acute cerebral infarctions Chinese Journal of Neurology (full reference awaited) 2002"},{"key":"10.1002\/14651858.CD000213-BIB22|cit22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021011","article-title":"Letter to the editor","volume":"275","author":"Ciccone","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.STR.30.12.2631","article-title":"Neurological deterioration in acute ischaemic stroke. Potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I.","volume":"30","author":"Davalos","year":"1999","journal-title":"Stroke"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000213-BIB24|cit24","first-page":"29","article-title":"Very early identification of lacunar infarcts in the ECASS Study","volume":"7","year":"1997","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke","volume":"274","year":"1995","journal-title":"The Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000213-BIB26|cit26","series-title":"The Challenge of Stroke Lancet Conference Book of Abstracts, Montreal 15-16 October 1999","first-page":"35","article-title":"Frequency and consequences of medical complications of ischaemic stroke.","author":"Fieschi","year":"1999"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB27|cit27","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS 1 and ECASS II placebo cohorts.","volume":"9","author":"Fiorelli","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct. Relationships with early clinical deterioration and three month outcome in the European Cooperative Acute Stroke Study I (ECASS I) Cohort.","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213-BIB29|cit29","first-page":"19","article-title":"Cortical extension of the infarction at 24 hours in patients with isolated hypodensity of the lentiform nucleus on 1 - 6 hour CT : Incidence, predictors and outcome in the ECASS 1 Cohort (Abstract)","volume":"8","author":"Fiorelli","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jama.1995.03530130064029","article-title":"ECASS: Lessons for future thrombolytic stroke trials","volume":"274","author":"Fisher","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.STR.29.10.2073","article-title":"Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set. Post hoc analysis of ECASS 1","volume":"29","author":"Hacke","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB32|cit32","first-page":"984","article-title":"Reply to letter to the editor","volume":"275","author":"Hacke","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213-BIB33|cit33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.STR.29.10.2073","article-title":"Dichotomised endpoints and combined global endpoint statistics applied to the ECASS intention-to-treat data set (Abstract)","volume":"29","author":"Hacke","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB34|cit34","first-page":"272","article-title":"rt-PA in acute ischaemic stroke - results from the ECASS three hour cohort.","volume":"28","author":"Hacke","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB36|cit35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/978-3-642-78061-5_10","article-title":"The European Cooperative Acute Stroke Study (ECASS)","volume-title":"Thrombolytic Therapy in Acute Ischaemic Stroke","author":"Kaste","year":"1993"},{"key":"10.1002\/14651858.CD000213-BIB37|cit36","article-title":"A post-hoc risk\/benefit assessment for mortality and handicap in 615 ECASS patients randomised and treated","volume":"Suppl 53","author":"Kaste","year":"1997","journal-title":"Up J Med Sci"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB38|cit37","first-page":"S20","article-title":"Risk\/benefit assessment for mortality and handicap among 615 patients randomised and treated in ECASS","volume":"5","author":"Kaste","year":"1998","journal-title":"Eur J Neurol"},{"key":"10.1002\/14651858.CD000213-BIB39|cit38","first-page":"288","article-title":"Risk\/benefit assessment for mortality and handicap in ECASS randomised and treated patients: A post-hoc analysis (abstract)","volume":"29","author":"Kaste","year":"1998","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB40|cit39","first-page":"129","article-title":"Potential contributors for good vs bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6","author":"Kaste","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB35|cit40","first-page":"181","article-title":"Potential contributors to bad functional outcome or death in European Cooperative Acute Stroke Study (ECASS)","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB42|cit41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","article-title":"Hemorrhagic transformation in acute ischaemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study","volume":"28","author":"Larrue","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB41|cit42","first-page":"181","article-title":"Predictors of hemorrhagic transformation in the ECASS trial","volume":"6","author":"Larrue","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB43|cit43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.STR.30.4.769","article-title":"Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.","volume":"30","author":"Manelfe","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213-BIB44|cit44","first-page":"1","article-title":"A risk\/benefit assessment of 1.1 mg\/kg iv rt-PA in 615 acute stroke patients of ECASS","volume":"7","author":"Mau","year":"1997","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB45|cit45","first-page":"247","article-title":"Risk profile comparison in 615 patients randomised to either 1.1 mg\/kg intravenous rt-PA or placebo of ECASS 1.","volume":"30","author":"Mau","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB46|cit46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.STR.30.3.502","article-title":"Delayed increase in infarct volume after cerebral ischaemia. Correlations with thrombolytic treatment and clinical outcome.","volume":"30","author":"Pantano","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB47|cit47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000015851","article-title":"The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification","volume":"8","author":"Steiner","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB48|cit48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1468-1331.1995.tb00074.x","article-title":"European Cooperative Acute Stroke Study (ECASS): (rt-PA - Thrombolysis in acute stroke) study design and progress report","volume":"1","year":"1995","journal-title":"Eur J Neurol"},{"key":"10.1002\/14651858.CD000213-BIB49|cit49","first-page":"182","article-title":"Predictors of good outcome - ECASS trial","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB50|cit50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiology.205.2.9356611","article-title":"Acute stroke - usefulness of early CT findings before thrombolytic therapy","volume":"205","author":"Kummer","year":"1997","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD000213-BIB54|cit51","first-page":"13","article-title":"Letter to the editor","volume":"275","author":"Kummer","year":"1996","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB51|cit52","first-page":"129","article-title":"Causes of death in ECASS","volume":"6","author":"Willig","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB52|cit53","first-page":"272","article-title":"Heparin effects in the European Cooperative Acute Stroke Study","volume":"28","author":"Willig","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB53|cit54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03530370021010","article-title":"Letter to the editor","volume":"275","author":"Wood","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213-BIB55|cit55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74844-3","article-title":"Letter to the editor","volume":"353","author":"Barer","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.STR.31.7.1545","article-title":"Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischaemic stroke and thrombolytic therapy","volume":"31","author":"Berrouschot","year":"2000","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB57|cit57","first-page":"95","article-title":"Reperfusion after focal cerebral ischaemia does not increase the rate and severity of secondary haemorrhage (abstract)","volume":"9","author":"Berrouschot","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB58|cit58","first-page":"267","article-title":"Thrombolysis with rt-PA: A SPECT study","volume":"30","author":"Berrouschot","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB59|cit59","first-page":"33","article-title":"Type of acute stroke care, stroke outcome and safety parameters in the ECASS II trial: the Spanish experience","volume":"9","author":"Davalos","year":"1999","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213-BIB60|cit60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000047549","article-title":"Fibrinolytic therapy for acute stroke: the Spanish experience","volume":"9","author":"Davalos","year":"1999","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB61|cit61","first-page":"128","article-title":"Final results of the second European-Australasian Acute Stroke Study of intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"9","author":"Fieschi","year":"1999","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB62|cit62","first-page":"14","article-title":"Natural history of ischaemic stroke in ECASS I and ECASS II placebo cohorts","volume":"9","author":"Fiorelli","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB63|cit63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(98)00005-1","article-title":"ECASS II: Intravenous alteplase in acute ischaemic stroke","volume":"353","author":"Ford","year":"1999","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1002\/14651858.CD000213-BIB67|cit64","first-page":"S9","article-title":"The results of the European Co-operative Stroke Study II (ECASS II), a placebo-controlled, randomized study of thrombolytic therapy","volume":"5","author":"Hacke","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD000213-BIB64|cit65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74842-X","article-title":"Authors' reply","volume":"353","author":"Hacke","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB66|cit66","series-title":"The Challenge of Stroke Lancet Conference Montreal, 15-16 October 1999, Book of Abstracts","article-title":"Thrombolysis in acute ischaemic stroke: ECASS II","author":"Hacke","year":"1999"},{"key":"10.1002\/14651858.CD000213-BIB65|cit67","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB68|cit68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)74843-1","article-title":"Letter to the editor","volume":"353","author":"Jenkinson","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB69|cit69","first-page":"278","article-title":"Risk factors for haemorrhagic transformation in ECASS II","volume":"31","author":"Larrue","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB70|cit70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.STR.32.2.438","article-title":"Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinanat tissue plasminogen activator","volume":"32","author":"Larrue","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB71|cit71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(05)74846-7","article-title":"Letter to the editor","volume":"353","author":"Lees","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB72|cit72","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(05)74845-5","article-title":"Letter to the editor","volume":"353","author":"Raha","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000213-BIB73|cit73","first-page":"82","article-title":"European-Australian cooperative acute stroke study II (ECASS II) - interim demographics and baseline characteristics (Abstract)","volume":"8","author":"Schaefer","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB74|cit74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000047608","article-title":"Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?","volume":"11","author":"Stingele","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB75|cit75","first-page":"275","article-title":"The effect of early and late brain tissue reperfusion on infarct volume","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.STR.24.7.1000","article-title":"Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Iscemic Stroke","volume":"24","author":"Haley","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB77|cit77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000108714","article-title":"Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke","volume":"3","author":"Yamaguchi","year":"1993","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB78|cit78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-78061-5_9","article-title":"Intravenous tissue plasminogen activator in acute thromboembolic stroke: A placebo controlled, double blind trial","volume-title":"Thrombolytic Therapy in Acute Ischemic Stroke II","author":"Yamaguchi","year":"1993"},{"key":"10.1002\/14651858.CD000213-BIB79|cit79","first-page":"183","article-title":"Multicentre Acute Stroke Trial-Europe: Predictors of good outcome","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB80|cit80","first-page":"182","article-title":"Multicentre Acute Stroke Trial-Europe: risk factors for the development of oedema, haemorrhage, bad neurological, bad functional outcome and death","volume":"6","author":"Hommel","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB81|cit81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(95)91179-0","article-title":"Termination of trial of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Hommel","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB82|cit82","first-page":"578","article-title":"Authors' reply","volume":"345","author":"Hommel","year":"1995","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000213-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.STR.30.7.1326","article-title":"Haemorrhagic transformation in acute ischaemic stroke. The MAST-E Study.","volume":"30","author":"Jaillard","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB84|cit84","first-page":"797","article-title":"Predictive factors related to outcome at one year after intravenous thrombolysis: the MAST-E Study","volume":"10","author":"Jaillard","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB85|cit85","first-page":"2887","article-title":"Predictive factors related to outcome at one year after iv thrombolysis: the MAST-E Study","volume":"31","author":"Jaillard","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB86|cit86","first-page":"182","article-title":"Haemorrhagic transformation in MAST-E trial: predictive factors","volume":"6","author":"Moulin","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB87|cit87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischaemic stroke","volume":"335","author":"Cornu","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB88|cit88","first-page":"129","article-title":"Long term effect of thrombolytic treatment in acute ischaemic stroke","volume":"6","author":"Aritzu","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB89|cit89","first-page":"190","article-title":"Prognostic value of haemorrhagic transformation in acute ischaemic stroke","volume":"6","author":"Aritzu","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB90|cit90","first-page":"391","article-title":"Letter to the editor","volume":"347","author":"Barer","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB97|cit91","series-title":"Book of Abstracts Proceedings of the 6th International Conference on Thrombolysis in Acute Ischaemic Stroke, Hamilton Island, Nov 2000","first-page":"3","article-title":"The long term effects of acute treatment with streptokinase and\/or aspirin","author":"Candelise","year":"2000"},{"key":"10.1002\/14651858.CD000213-BIB92|cit92","first-page":"393","article-title":"Multicentre Acute Stroke Trial - Italy ( Authors' Reply)","volume":"347","author":"Candelise","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB93|cit93","first-page":"393","article-title":"Authors' reply","volume":"347","author":"Candelise","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD000213-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/01.STR.31.7.1785","article-title":"Letter to the editor","volume":"31","author":"Candelise","year":"2000","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB95|cit95","first-page":"23","article-title":"Aspirin given within six hours reduces long term case fatality but not stroke related disability","volume":"6","author":"Candelise","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB96|cit96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01995705","article-title":"Thrombolytic therapy. From myocardial to cerebral infarction","volume":"17","author":"Candelise","year":"1996","journal-title":"Ital J neurol Sci"},{"key":"10.1002\/14651858.CD000213-BIB91|cit97","first-page":"181","article-title":"Risk factors in the MAST-Italy Trial","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB98|cit98","first-page":"392","article-title":"Letter to the editor","volume":"347","author":"Carolei","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB100|cit99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000016026","article-title":"Negative interaction of aspirin and streptokinase in acute ischaemic stroke: Further analysis of the Multicentre Acute Stroke Trial-Italy","volume":"10","author":"Ciccone","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB99|cit100","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(05)60007-4","article-title":"Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis","volume":"352","author":"Ciccone","year":"1998","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000213-BIB101|cit101","first-page":"129","article-title":"Aspirin in combination with thrombolysis increases the risk of early death but not of intracranial bleeding in patients with acute ischaemic stroke.","volume":"6","author":"Motto","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB102|cit102","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.STR.30.4.761","article-title":"Haemorrhage after an acute ischaemic stroke","volume":"30","author":"Motto","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB103|cit103","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(96)90568-1","article-title":"Letter to the editor","volume":"347","author":"Muir","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","author":"Aritzu","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB105|cit105","first-page":"393","article-title":"Letter to the editor","volume":"347","author":"Rothwell","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(95)92044-7","article-title":"Thrombolytic therapy for acute ischaemic stroke: promising, perilous or unproven?","volume":"346","author":"Sandercock","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB107|cit107","first-page":"198","article-title":"Is thrombolysis useful for acute stroke patients? The experience of the MAST-I Study","volume-title":"Thrombolytic Therapy in Acute Ischaemic Stroke","year":"1995"},{"key":"10.1002\/14651858.CD000213-BIB108|cit108","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(95)92050-1","article-title":"Dissent: an alternative interpretation of MAST-I","volume":"346","author":"Tognoni","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB109|cit109","first-page":"183","article-title":"Predictors of good outcome in the MAST-I trial","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB110|cit110","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.42.5.976","article-title":"Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke","volume":"42","author":"Mori","year":"1992","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213-BIB111|cit111","first-page":"727","article-title":"A pilot study of streptokinase for acute cerebral infarction","volume":"88","author":"Morris","year":"1995","journal-title":"Q J Med"},{"key":"10.1002\/14651858.CD000213-BIB118|cit112","unstructured":"Food and Drug Administration http:\/\/www.fda.gov\/cber\/products\/altegen061896.htm see Clinical Review 2"},{"issue":"5","key":"10.1002\/14651858.CD000213-BIB112|cit113","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/labmed\/27.5.296","article-title":"Heart treatment reduces damage from stroke","volume":"27","author":"Anonymous","year":"1996","journal-title":"Laboratory Medicine"},{"key":"10.1002\/14651858.CD000213-BIB113|cit114","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01376517-199712000-00006","article-title":"Nursing management of acute complications following rt-PA in acute ischaemic stroke","volume":"29","author":"Barch","year":"1997","journal-title":"J Neurosci Nurs"},{"issue":"11","key":"10.1002\/14651858.CD000213-BIB114|cit115","first-page":"2828","article-title":"Apo E Phenotype and the efficacy of intravenous t-PA in acute ischemic stroke","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB115|cit116","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.STR.31.10.2335","article-title":"Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS t-PA Stroke Trial","volume":"31","author":"Broderick","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB116|cit117","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/01.STR.29.8.1504","article-title":"Hypertension and its treatment in the NINDS rt-PA Stroke Trial","volume":"29","author":"Brott","year":"1998","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB146|cit118","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke; letter to the editor - authors' reply","volume":"334","author":"Zoppo","year":"1996","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000213-BIB117|cit119","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.50.4.883","article-title":"Cost-effectiveness of tissue plasminogen activator for acute ischaemic stroke","volume":"50","author":"Fagan","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213-BIB119|cit120","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199605233342114","article-title":"Tissue plasminogen activator for acute ischaemic stroke; letter to the editor","volume":"334","author":"Freidman","year":"1996","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000213-BIB120|cit121","first-page":"online","article-title":"The NINDS Stroke Study Group Response","volume":"electronic lett","author":"Grotta","journal-title":"Br Med J online"},{"key":"10.1002\/14651858.CD000213-BIB121|cit122","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.STR.30.8.1528","article-title":"Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.","volume":"30","author":"Grotta","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB122|cit123","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.STR.32.3.661","article-title":"Clinical deterioration following improvement in the NINDS rt-PA stroke trial","volume":"32","author":"Grotta","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB123|cit124","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0196-0644(97)99996-0","article-title":"Myths regarding the NINDS rt-PA Stroke Trial: Setting the record straight","volume":"30","author":"Haley","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1002\/14651858.CD000213-BIB124|cit125","series-title":"Cerebrovasc Dis","first-page":"125","article-title":"Initial findings of the rt-PA acute stroke treatment review panel","author":"Ingall","year":"2003"},{"key":"10.1002\/14651858.CD000213-BIB125|cit126","first-page":"1405","article-title":"Tissue plasminogen activator for acute ischaemic stroke; letter to the editor","volume":"334","author":"Koroshetz","year":"1999","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000213-BIB126|cit127","first-page":"288","article-title":"The NINDS RT-PA stroke study - sustained benefit at one year (abstract)","volume":"29","author":"Kwiatkowski","year":"1998","journal-title":"Stroke"},{"issue":"23","key":"10.1002\/14651858.CD000213-BIB127|cit128","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischaemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"New Eng J Med"},{"issue":"5","key":"10.1002\/14651858.CD000213-BIB128|cit129","first-page":"757","article-title":"Questioning thrombolytic use for cerebrovascular accidents","volume":"16","author":"Li","year":"1998","journal-title":"The Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD000213-BIB129|cit130","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.STR.30.11.2347","article-title":"Underlying structure of the National Institutes of Health Stroke Scale. Results of a factor analysis","volume":"30","author":"Lyden","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB130|cit131","first-page":"307","article-title":"Underlying structure of the NIH Stroke Scale. Results of a factor analysis","volume":"31","author":"Lyden","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB132|cit132","first-page":"244","article-title":"Earlier treatment associated with better outcome in the NINDS t-PA Stroke Study","volume":"30","author":"Marler","year":"1999","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB131|cit133","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke; letter to the editor - authors' reply","volume":"334","year":"1999","journal-title":"NEJM"},{"issue":"167","key":"10.1002\/14651858.CD000213-BIB133|cit134","first-page":"28","article-title":"Recent results from the NINDS-tPA trial","volume":"94","author":"Morgenstern","year":"1996","journal-title":"Acta Neurol Scand - Proceedings of the 31st Scandinavian Congress of Neurology"},{"key":"10.1002\/14651858.CD000213-BIB134|cit135","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1001\/jama.286.22.2830","article-title":"Lack of clinical significance of early ischaemic changes on computed tomography in acute stroke","volume":"286","author":"Patel","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000213-BIB135|cit136","first-page":"1406","article-title":"Tissue plasminogen activator for acute ischaemic stroke; letter to the editor","volume":"334","author":"Quereshi","year":"1999","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000213-BIB143|cit137","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue Plasminogen Activator for Acute Ischaemic Stroke","volume":"333","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000213-BIB136|cit138","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.STR.28.8.1530","article-title":"A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centres and implications for community practice and patient care","volume":"28","year":"1997","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD000213-BIB137|cit139","first-page":"2828","article-title":"Effect of rt-PA on CT lesion volume over time","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB138|cit140","series-title":"Proceedings of the 23rd International Joint Conference on Stroke and Cerebral Circulation","article-title":"Effect of rt-PA on ischaemic stroke lesion size by computed tomography: preliminary results from the NINDS rt-PA Stroke Trial","year":"1998"},{"key":"10.1002\/14651858.CD000213-BIB139|cit141","first-page":"181","article-title":"Predictors of an unfavourable outcome","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB140|cit142","first-page":"182","article-title":"Predictors of favourable outcome","volume":"6","year":"1996","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB141|cit143","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.STR.28.11.2119","article-title":"Generalised efficacy of t-PA for Acute Stroke: Subgroup analysis of the NINDS t-PA Stroke Trial","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB142|cit144","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral haemorrhage after intravenous t-PA therapy for ischaemic stroke","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB144|cit145","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archneur.1997.00550240020008","article-title":"Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke","volume":"54","author":"Tilley","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1002\/14651858.CD000213-BIB147|cit146","first-page":"231","article-title":"Letter to the editor","volume":"31","author":"Kummer","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB145|cit147","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/01.STR.0000030108.47462.4F","article-title":"Safety of tissue plasminogen activator for acute stroke in menstruating women","volume":"33","author":"Wein","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB148|cit148","first-page":"445","article-title":"Clinical efficacy of urokinase in patients with cerebral thrombosis: multicentre double blind study (translation from Japanese awaited)","volume":"19","author":"Ohtomo","year":"1985","journal-title":"Kiso-to-Rinshyo (Basic and Clinical)"},{"issue":"3","key":"10.1002\/14651858.CD000213-BIB149|cit149","first-page":"711","article-title":"Clinical efficacy of urokinase in the treatment of cerebral thrombosis. Multi-center double-blind study in comparison with placebo (translated from Japanese)","volume":"15","author":"Ohtomo","year":"1985","journal-title":"Clin-Eval"},{"key":"10.1002\/14651858.CD000213-BIB151|cit150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: A phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke","volume":"29","author":"Zoppo","year":"1998","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD000213-BIB150|cit151","first-page":"171","article-title":"The clinical trials acceleration program: experience from the Prolyse in Acute Cerebral Thromboembolism Trial (PROACT)","volume":"27","author":"Furlan","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB152|cit152","series-title":"Proceedings of the 23rd Joint International Conference on Stroke and Cerebral Circulation, Orlando, Florida, Feb 5-7","article-title":"PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism","author":"Furlan","year":"1998"},{"key":"10.1002\/14651858.CD000213-BIB153|cit153","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intraarterial Pro-Urokinase for acute ischaemic stroke. The PROACT II Study: A randomised controlledd trial.","volume":"282","author":"Furlan","year":"1999","journal-title":"Journal of the American Medical Association."},{"key":"10.1002\/14651858.CD000213-BIB154|cit154","first-page":"234","article-title":"Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: Initial trial results","volume":"30","author":"Furlan","year":"1999","journal-title":"Stroke"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD000213-BIB155|cit155","first-page":"A260","article-title":"Symptomatic intracranial hemorrhage after intraarterial thrombolysis with recombinant prourokinase in acute ischaemic stroke: The PROACT II Study","volume":"54","author":"Kase","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213-BIB156|cit156","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/str.32.suppl_1.336-b","article-title":"Angiographic collaterals in acute stroke - relationship to clinical presentation and outcome: The PROACT II Trial","volume":"32","author":"Roberts","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB157|cit157","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.STR.0000018011.66817.41","article-title":"Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischaemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial","volume":"33","author":"Roberts","year":"2002","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB158|cit158","first-page":"278","article-title":"Effect of intraarterial prourokinase on CT infarct volume: results of PROACT II","volume":"31","author":"Roberts","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB159|cit159","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/str.32.suppl_1.319","article-title":"Factors influencing outcome and treatment effect in PROACT II","volume":"32","author":"Wechsler","year":"2001","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213-BIB160|cit160","first-page":"111","article-title":"High dose urokinase in the treatment of acute ischaemic stroke (Chinese)","volume":"3","author":"Don-Cai","year":"1995","journal-title":"J of Brain and Neurological Diseases"},{"key":"10.1002\/14651858.CD000213-BIB161|cit161","first-page":"251","article-title":"Edinburgh Stroke Trial. A pilot study of intra-arterial thrombolysis for acute ischaemic stroke","volume":"57","author":"Wardlaw","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/14651858.CD000213-BIB162|cit162","unstructured":"Kumana C Hong Kong Trial of streptokinase vs placebo Unpublished"},{"key":"10.1002\/14651858.CD000213-BIB163|cit163","first-page":"213","article-title":"Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.","volume":"23","author":"Jin","year":"2000","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1002\/14651858.CD000213-BIB164|cit164","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.13.11.927","article-title":"Therapeutic thrombolysis in cerebral thromboembolism","volume":"13","author":"Meyer","year":"1963","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD000213-BIB165|cit165","first-page":"373","article-title":"Anticoagulants plus streptokinase therapy in progressing stroke","volume":"189","author":"Meyer","year":"1963","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000213-BIB166|cit166","first-page":"122","article-title":"Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis","volume":"113","author":"Naito","year":"1986","journal-title":"Folia-Haematol-(Leipz)"},{"issue":"4","key":"10.1002\/14651858.CD000213-BIB167|cit167","first-page":"229","article-title":"Clinical study of therapeutic effectiveness in treating ischaemic cerebrovascular disease with lumbrokinase","volume":"26","author":"Pang","year":"1993","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000213-BIB168|cit168","first-page":"313","article-title":"Randomised controlled trial of Crack Ahylysantifarctase intreating cerebral infarction (translated from Chinese)","volume":"16","author":"Yufeng","year":"1994","journal-title":"Beijing Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD000213-BIB169|cit169","first-page":"453","article-title":"Lumbrokinase in treating cerebral infarction","volume":"19","author":"Zhandong","year":"2000","journal-title":"Chinese Journal of New Drugs and Clinical Remedy"},{"key":"10.1002\/14651858.CD000213-BIB170|cit170","series-title":"Proceedings of the Fourth Chinese Stroke Conference, Chengdu, Oct","first-page":"44","article-title":"Thrombolytic therapy and external counterpulsation in acute cerebral infarction (abstract)","author":"Zhang Yuan","year":"1995"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB171|cit171","first-page":"S256","article-title":"Evaluation of intraarterial urokinase therapy in acute stroke","volume":"187","author":"Kandil","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1002\/14651858.CD000213-BIB172|cit172","first-page":"188","article-title":"Australian Urokinase Stroke Trial","volume":"6","author":"Davis","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213-BIB173|cit173","unstructured":"Desmoteplase in Acute Stroke Ongoing study"},{"key":"10.1002\/14651858.CD000213-BIB174|cit174","unstructured":"The Third European Co-operative Acute Stroke Study Ongoing study 010103"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000213-BIB176|cit175","first-page":"106","article-title":"The EUropean Multicentre Four-Arm Trial in Acute Stroke Project (EMFATAS): A European Union Work - program on health research.","volume":"9","author":"Fieschi","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD000213-BIB175|cit176","first-page":"192","article-title":"The EMPHATAS project: a four-arm safety and efficacy European trial","volume":"6","author":"Fieschi","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD000213-BIB177|cit177","unstructured":"EPITHET - Echoplanar Imaging Thrombolytic Evaluation Trial. Ongoing study"},{"key":"10.1002\/14651858.CD000213-BIB178|cit178","doi-asserted-by":"crossref","unstructured":"Sandercock PAG LIndley RI Third International Stroke Trial (IST-3) Stroke (http:\/\/stroke.ahajournals.org\/cgi\/content\/full\/34\/2\/e1) 2003","DOI":"10.1161\/01.STR.0000047037.38062.24"},{"key":"10.1002\/14651858.CD000213-BIB179|cit179","unstructured":"IA Urokinase trial Ongoing study"},{"key":"10.1002\/14651858.CD000213-BIB180|cit180","unstructured":"PROACT III Ongoing study"},{"key":"10.1002\/14651858.CD000213-BIB181|cit181","unstructured":"SYNTHESIS (Local versus systemic thrombolysis for acute stroke) Ongoing study 2002"},{"key":"10.1002\/14651858.CD000213-BIB182|cit182","unstructured":"unknown Ongoing study"},{"key":"10.1002\/14651858.CD000213-BIB183|cit183","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000213-BIB184|cit184","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis","volume-title":"Systematic Reviews in Health Care: Metaanalysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD000213-BIB185|cit185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/hcg016","article-title":"Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review","volume":"96","author":"Dundar","year":"2003","journal-title":"Q J Med"},{"key":"10.1002\/14651858.CD000213-BIB186|cit186","volume-title":"A systematic review of the effectiveness, cost-effectiveness and barriers to the implementation of thrombolytic and neuroprotective treatment in the NHS","author":"Sandercock","year":"2002"},{"key":"10.1002\/14651858.CD000213-BIB187|cit187","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0967-5868(99)90596-9","article-title":"Thrombolysis in acute stroke pooling project: a metaanalysis on individual patient data","volume":"6","author":"Cornu","year":"1999","journal-title":"J Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000213-BIB188|cit188","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.STR.0000016923.99605.75","article-title":"Brain haemorrhage after thrombolysis: good or bad?","volume":"33","author":"Kummer","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD000213-BIB189|cit189","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000213","article-title":"Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke","author":"Wardlaw","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000213-BIB190|cit190","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.STR.31.5.1133","article-title":"Trials of thrombolysis in acute ischaemic stroke - does the choice of primary outcome measure really matter?","volume":"31","author":"Wardlaw","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD000213-BIB191|cit191","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ewjm.176.3.198","article-title":"Thrombolysis for acute ischaemic stroke: still a treatment for the few by the few","volume":"176","author":"Wardlaw","year":"2002","journal-title":"West J Med"},{"key":"10.1002\/14651858.CD000213-BIB192|cit192","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.STR.23.12.1826","article-title":"Thrombolysis in acute ischaemic stroke - Does it work?","volume":"23","author":"Wardlaw","year":"1992","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD000213-BIB193|cit193","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(97)03022-5","article-title":"Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke","volume":"350","author":"Wardlaw","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000213-BIB194|cit194","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/01.STR.0000072513.72262.7E","article-title":"Thrombolytic therapy with rt-PA for acute ischaemic stroke: where do we go from here? A cumulative meta-analysis","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:58:41Z","timestamp":1682589521000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000213"}},"subtitle":[],"editor":[{"given":"Joanna M","family":"Wardlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":194,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000213","relation":{},"subject":[],"published":{"date-parts":[[2003,7,21]]}}}